Shares of Biogen Inc. BIIB shed 1.16% to $141.43 Wednesday, on what proved to be an all-around great trading session for the ...

Bullish option flow detected in Biogen (BIIB) with 2,540 calls trading, 1.1x expected, and implied vol increasing over 2 points to 35.32%.

In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of ...

Eisai and Biogen have moved swiftly ahead with regulatory filings for their new Alzheimer's therapy lecanemab in the EU, after getting a green light for the anti-amyloid beta antibody in the US ...

Discover 7 key signs that indicate it's time to refresh or change your company logo design for better branding and business growth this year. $3.2 million. That's what the average logo redesign costs ...

Revenue 0.00-2.47 1.62 ...

Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition ...